Research status of premyopia
10.3980/j.issn.1672-5123.2024.7.18
- VernacularTitle:近视前期的研究现状
- Author:
Yitong LIN
1
,
2
;
Ziyang CHEN
1
,
2
;
Zhaoda YE
1
,
2
;
Sheng CHEN
1
,
2
;
Yanhong HU
1
,
2
Author Information
1. Fujian University of Traditional Chinese Medicine, Fuzhou 350122, Fujian Province, China
2. Department of Ophthalmology, the Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou 350003, Fujian Province, China
- Publication Type:Journal Article
- Keywords:
premyopia;
atropine;
red light therapy;
plano defocus;
prevention and control strategies
- From:
International Eye Science
2024;24(7):1102-1105
- CountryChina
- Language:Chinese
-
Abstract:
The visual impairment and blindness caused by myopia have become a global burden, and the World Health Organization has included the prevention and control of myopia in the global program for preventing blindness. In China, the development of myopia is showing a trend with higher incidence, younger age, and higher refractive errors. Moving forward the port of prevention and control myopia has become an important strategy to address the current predicament. Premyopia refers to the stage in children where the refractive power is ≤+0.75 D and >-0.50 D, and there are multiple risk factors during this stage that can potentially lead to myopia. Currently, the incidence of premyopia and its transformation into myopia is high, and the key prevention and control measures include building a predictive model for the transformation of premyopia into myopia, emphasizing the reduction of exposure to risk factors, using low-concentration atropine eye drops, red light therapy, and optical defocus intervention. This article provides a comprehensive review of the current situation regarding the incidence of premyopia and its transformation into myopia, as well as the research progress on existing prevention and control measures, with the aim of providing relevant references for the prevention and control of myopia during the premyopia stage.
